Patent details

90466 Product Name: 5-méthylisoxazole-4-acide carboxylique-4-trifluorométhylanilide (INN leflunomide) (ARAVA®)

Basic Information

Publication number:
90466
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP791051428
Legal Status:
Expired
Application number:
90466
First applicant's nationality:
Procedural language:
French

Marketing Authorization

1

Marketing Authorization Number:
EU/1/99/118/001 à EU/1/99/118/009
Marketing Authorization Type:
Marketing Authorization Date:
02/09/1999
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

2

Marketing Authorization Number:
IKS No.54834
Marketing Authorization Type:
Marketing Authorization Date:
23/12/1998
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Switzerland (CH)

Dates

Filing date:
27/10/1999
First Marketing Authorization date:
23/12/1998
Grant date:
27/12/1999
Activation date:
13/12/1999
Publication date:
27/12/1999
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
13/12/2004
SPC Extension Expiration:
13/12/2004
Rejection date:
Withdrawal date:

Owner

From:
07/03/2001
 
 

Name:
AVENTIS PHARMA DEUTSCHLAND GMBH
Address:
BRÜNINGSTRASSE 50, 65929, FRANKFURT, Germany (DE)

History of Owners

From:
27/10/1999
To:
06/03/2001

Name:
HOECHST AKTIENGESELLSCHAFT
Address:
POSTFACH 80 03 20, D-65926 FRANKFURT/MAIN 80, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
27/10/1999
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
Filing date Document type Number of pages